Korean pine nut oil replacement decreases intestinal lipid uptake while improves hepatic lipid metabolism in mice
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: Consumption of pine nut oil (PNO) was shown to reduce weight gain and attenuate hepatic steatosis in mice fed a high-fat diet (HFD). The aim of this study was to examine the effects of PNO on both intestinal and hepatic lipid metabolism in mice fed control or HFD. MATERIALS/METHODS: Five-week-old C57BL/6 mice were fed control diets containing 10% energy fat from either Soybean Oil (SBO) or PNO, or HFD containing 15% energy fat from lard and 30% energy fat from SBO or PNO for 12 weeks. Expression of genes related to intestinal fatty acid (FA) uptake and channeling (Cd36, Fatp4, Acsl5, Acbp), intestinal chylomicron synthesis (Mtp, ApoB48, ApoA4), hepatic lipid uptake and channeling (Lrp1, Fatp5, Acsl1, Acbp), hepatic triacylglycerol (TAG) lipolysis and FA oxidation (Atgl, Cpt1a, Acadl, Ehhadh, Acaa1), as well as very low-density lipoprotein (VLDL) assembly (ApoB100) were determined by real-time PCR. RESULTS: In intestine, significantly lower Cd36 mRNA expression (P<0.05) and a tendency of lower ApoA4 mRNA levels (P = 0.07) was observed in PNO-fed mice, indicating that PNO consumption may decrease intestinal FA uptake and chylomicron assembly. PNO consumption tended to result in higher hepatic mRNA levels of Atgl (P = 0.08) and Cpt1a (P = 0.05). Significantly higher hepatic mRNA levels of Acadl and ApoB100 were detected in mice fed PNO diet (P<0.05). These results suggest that PNO could increase hepatic TAG metabolism; mitochondrial fatty acid oxidation and VLDL assembly. CONCLUSIONS: PNO replacement in the diet might function in prevention of excessive lipid uptake by intestine and improve hepatic lipid metabolism in both control diet and HFD fed mice.
Abstract
BACKGROUND/OBJECTIVES: Consumption of pine nut oil (PNO) was shown to reduce weight gain and attenuate hepatic steatosis in mice fed a high-fat diet (HFD). The aim of this study was to examine the effects of PNO on both intestinal and hepatic lipid metabolism in mice fed control or HFD. MATERIALS/METHODS: Five-week-old C57BL/6 mice were fed control diets containing 10% energy fat from either Soybean Oil (SBO) or PNO, or HFD containing 15% energy fat from lard and 30% energy fat from SBO or PNO for 12 weeks. Expression of genes related to intestinal fatty acid (FA) uptake and channeling (Cd36, Fatp4, Acsl5, Acbp), intestinal chylomicron synthesis (Mtp, ApoB48, ApoA4), hepatic lipid uptake and channeling (Lrp1, Fatp5, Acsl1, Acbp), hepatic triacylglycerol (TAG) lipolysis and FA oxidation (Atgl, Cpt1a, Acadl, Ehhadh, Acaa1), as well as very low-density lipoprotein (VLDL) assembly (ApoB100) were determined by real-time PCR. RESULTS: In intestine, significantly lower Cd36 mRNA expression (P<0.05) and a tendency of lower ApoA4 mRNA levels (P = 0.07) was observed in PNO-fed mice, indicating that PNO consumption may decrease intestinal FA uptake and chylomicron assembly. PNO consumption tended to result in higher hepatic mRNA levels of Atgl (P = 0.08) and Cpt1a (P = 0.05). Significantly higher hepatic mRNA levels of Acadl and ApoB100 were detected in mice fed PNO diet (P<0.05). These results suggest that PNO could increase hepatic TAG metabolism; mitochondrial fatty acid oxidation and VLDL assembly. CONCLUSIONS: PNO replacement in the diet might function in prevention of excessive lipid uptake by intestine and improve hepatic lipid metabolism in both control diet and HFD fed mice.
참고문헌 (37)
- de Wit N, "Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine", Am J Physiol Gastrointest Liver Physiol, 303, pp.G589~G599 (2012)
- Abumrad NA, "Role of the gut in lipid homeostasis", Physiol Rev, 92, pp.1061~1085 (2012)
- Nguyen P, "Liver lipid metabolism", J Anim Physiol Anim Nutr (Berl), 92, pp.272~283 (2008)
- Kim S, "Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model", Gene, 340, pp.99~109 (2004)
- Fabbrini E, "Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications", Hepatology, 51, pp.679~689 (2010)
- Turpin SM, "Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice", Diabetologia, 54, pp.146~156 (2011)
- Green CJ, "The influence of dietary fat on liver fat accumulation", Nutrients, 6, pp.5018~5033 (2014)
- Lee JW, "Selective increase in pinolenic acid (all-cis-5,9,12-18:3) in Korean pine nut oil by crystallization and its effect on LDL-receptor activity", Lipids, 39, pp.383~387 (2004)
- Ferramosca A, "Pinus koraiensis seed oil (PinnoThinTM) supplementation reduces body weight gain and lipid concentration in liver and plasma of mice", J Anim Feed Sci, 17, pp.621~630 (2008)
- Asset G, "Effects of Pinus pinaster and Pinus koraiensis seed oil supplementation on lipoprotein metabolism in the rat", Lipids, 34, pp.39~44 (1999)
- 박소영, "Impact of Korean pine nut oil on weight gain and immune responses in high-fat diet-induced obese mice", Nutrition Research and Practice, 7(5), pp.352~358 (2013), 한국영양학회
- Le NH, "Diet enriched with Korean pine nut oil improves mitochondrial oxidative metabolism in skeletal muscle and brown adipose tissue in diet-induced obesity", J Agric Food Chem, 60, pp.11935~11941 (2012)
- Folch J, "A simple method for the isolation and purification of total lipides from animal tissues", J Biol Chem, 226, pp.497~509 (1957)
- Petit V, "Chronic high-fat diet affects intestinal fat absorption and postprandial triglyceride levels in the mouse", J Lipid Res, 48, pp.278~287 (2007)
- Huang W, "Octreotide promotes weight loss via suppression of intestinal MTP and apoB48expression in diet-induced obesity rats", Nutrition, 29, pp.1259~1265 (2013)
- Iqbal J, "Intestinal lipid absorption", Am J Physiol Endocrinol Metab, 296, pp.E1183~E1194 (2009)
- Black DD., "Development and physiological regulation of intestinal lipid absorption. I. Development of intestinal lipid absorption:cellular events in chylomicron assembly and secretion", Am J Physiol Gastrointest Liver Physiol, 293, pp.G519~G524 (2007)
- Lu S, "Overexpression of apolipoprotein A-IV enhances lipid secretion in IPEC-1 cells by increasing chylomicron size", J Biol Chem, 281, pp.3473~3483 (2006)
- Stan S, "Apo A-IV: an update on regulation and physiologic functions", Biochim Biophys Acta, 1631, pp.177~187 (2003)
- Mortimer BC, "Intracellular localization and metabolism of chylomicron remnants in the livers of low density lipoprotein receptor-deficient mice and apoEdeficient mice. Evidence for slow metabolism via an alternative apoE-dependent pathway", J Biol Chem, 270, pp.28767~28776 (1995)
- Nestel PJ, "Sites of initial removal of chylomicron triglyceride fatty acids from the blood", J Clin Invest, 41, pp.1915~1921 (1962)
- Lillis AP, "LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies", Physiol Rev, 88, pp.887~918 (2008)
- Masson O, "LRP1 receptor controls adipogenesis and is up-regulated in human and mouse obese adipose tissue", PLoS One, 4, pp.e7422~ (2009)
- Willnow TE., "Mechanisms of hepatic chylomicron remnant clearance", Diabet Med, 14(Suppl 3), pp.S75~S80 (1997)
- Donnelly KL, "Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease", J Clin Invest, 115, pp.1343~1351 (2005)
- Hardwick JP, "PPAR", RXR regulation of fatty acid metabolism and fatty acid omega-hydroxylase (CYP4) isozymes: implications for prevention of lipotoxicity in fatty liver disease, 2009, pp.2009, 952734~
- Adiels M, "Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome", Arterioscler Thromb Vasc Biol, 28, pp.1225~1236 (2008)
- Grenier-Larouche T, "Metabolic inflexibility of white and brown adipose tissues in abnormal fatty acid partitioning of type 2 diabetes", Int J Obes Suppl, 2, pp.S37~S42 (2012)
- Bjørndal B, "Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents", J Obes, 2011, pp.490650~ (2011)
- Ong KT, "Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning", Hepatology, 53, pp.116~126 (2011)
- Guo Y, "Underlying mechanisms of pharmacology and toxicity of a novel PPAR agonist revealed using rodent and canine hepatocytes", Toxicol Sci, 96, pp.294~309 (2007)
- van der Leij FR, "Gene expression profiling in livers of mice after acute inhibition of beta-oxidation", Genomics, 90, pp.680~689 (2007)
- Millar JS, "Short-term overexpression of DGAT1 or DGAT2 increases hepatic triglyceride but not VLDL triglyceride or apoB production", J Lipid Res, 47, pp.2297~2305 (2006)
- Miccoli R, "Insulin resistance and lipid disorders", Future Lipidol, 3, pp.651~664 (2008)
- Heath RB, "Selective partitioning of dietary fatty acids into the VLDL TG pool in the early postprandial period", J Lipid Res, 44, pp.2065~2072 (2003)
- Geerling JJ, "Metformin lowers plasma triglycerides by promoting VLDLtriglyceride clearance by brown adipose tissue in mice", Diabetes, 63, pp.880~891 (2014)
- Cooper AD., "Hepatic uptake of chylomicron remnants", J Lipid Res, 38, pp.2173~2192 (1997)
